The IPM Guideline Development Team

Project Manager

Gill Hall - Accident Compensation Corporation (ACC)

The Expert Advisory Group

Dr John MacVicar (Chair) – New Zealand Association of Musculoskeletal Medicine

Dr John Barnard (from April 2004) – Australian and New Zealand College of Anaesthetists

Patsi Davies – University of Waikato; represents the consumer perspective

Mr Nicholas Finnis – Royal Australasian College of Surgeons (Neurosurgeon)

Dr Felicity Goodyear–Smith – Royal New Zealand College of General Practitioners

Mr Chris Hoffman – New Zealand Orthopaedic Association

Dr David Jansen – general practitioner; represents the Maori perspective

Dr David Jones – Faculty of Pain Medicine, Australian and New Zealand College of Anaesthetists

Dr Robert Large – Royal Australian and New Zealand College of Psychiatrists

Judy Leader - College of Nurses Aotearoa

Dr Marina Sew Hoy – Royal Australasian College of Physicians (Rheumatologist)

Professor Ted Shipton – New Zealand Pain Society

Dr Hugh Spencer (up to April 2004) - Australian and New Zealand College of Anaesthetists

Critical Appraisal Team

Ray Kirk (Director), Sarah Hancock, Ian Hodges, Catriona Mackay, Caroline Maskell - New Zealand Health Technology Assessment (NZHTA) unit

Pam Smartt, Claire Tochel - independent consultants

Siiri Bennett, Amanda Bowens, Gill Hall, Jill Nalder – ACC

Information and Library Team

Helen Brodie, Mai Dwairy, Aimee Hawker, Christine Powell, Flora Wallace – ACC

Ex-Officio Advisors

Ingrid Jaegers, Mary Leighton, Kevin Morris – ACC


Professor Henry McQuay, Professor of Pain Relief at the Nuffield Department of Anaesthetics, University of Oxford, provided comment on the clinical guidance

Dr Barrie Tait, Consultant Physician at the Christchurch School of Medicine, New Zealand, provided comment on the clinical guidance

Declaration of Competing Interests

Dr Felicity Goodyear-Smith has received funding from ACC for systematic literature reviews / meta-analyses and also for analysis and publication of ACC data.

Mr Chris Hoffman has received funding to support attendance at a number of orthopaedic workshops nationally and internationally.

Dr David Jansen has received funding from Auckland District Health Board, GlaxoSmithKline, Eli Lilly & Co. and ACC for consultancy work.

Dr David Jones has received a consulting honorarium from Pfizer (Australia).

Dr Robert Large received funding from MundiPharma, through the organisers of the Annual Scientific Meeting of the ANZCA Faculty of Pain Medicine, to speak in Perth in May 2004.

Dr Marina Sew-Hoy has received fees for speaking at a medical meeting funded by Merck, Sharp & Dohme and Pharmacia; and has participated in research trials funded by Allergan, GlaxoSmithKline and Celltech.

Professor Ted Shipton has received funding from Pharmacia for consultancy work.

Some members of the advisory group who are in clinical practice receive payments from ACC for the use of interventional pain management procedures.